
GHK-Cu (50 mg Vial)
GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways. This educational protocol presents practical subcutaneous administration approaches based on clinical practice patterns.
- Dose
- 1–3 mg per injection
- Frequency
- Once daily or every other day
- Timing
- Evening preferred
- Duration
- 8–12 weeks
Copper peptide. Promotes collagen synthesis and wound healing. Anti-inflammatory effects.
| Week/Phase | Dose per Injection | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 1.0 mg (1000 mcg) | 6 units (0.06 mL) |
| Weeks 5–8 | 1.5 mg (1500 mcg) | 9 units (0.09 mL) |
| Weeks 9–12+ | 2.0 mg (2000 mcg) | 12 units (0.12 mL) |
- •Peptide Vials (GHK-Cu, 50 mg each):
- •Insulin Syringes (U‑100, 29–31 gauge):
- •Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- •Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
Journal of Dermatological Science
GHK-Cu stimulates collagen synthesis in dermal fibroblasts and wound healing processes
View sourceWound Repair and Regeneration (Wiley)
Copper peptides in wound healing: tissue remodeling and collagen gene expression
View sourceInternational Journal of Molecular Sciences (PMC)
Regenerative and protective actions of GHK-Cu: gene regulation analysis
View sourceBiomaterials (Elsevier)
GHK modulation of metalloproteinases and tissue inhibitors in wound healing
View sourceDr Oracle AI
Clinical dosing patterns for GHK-Cu (1–2 mg subcutaneous protocols)
View sourceSalhab Pharmacy (Compounding Guidelines)
GHK-Cu injection protocols: 5 days/week and 3×/week dosing patterns
View sourceGenScript
Peptide storage and handling guidelines: lyophilized storage at −20 °C (−4 °F)
View sourcePeptide Sciences
Peptide storage best practices: temperature, humidity, and light protection
View sourceHappy Hormones MD (PDF)
GHK-Cu patient information: reconstituted storage at 2–8 °C (35.6–46.4 °F), 30-day use window
View sourceTocris Bioscience
Stability and storage: aliquoting peptide solutions to minimize freeze-thaw damage
View sourceGenScript
Avoiding repeated freeze-thaw cycles to prevent peptide degradation
View sourceRoswell Park Comprehensive Cancer Center
Injection site rotation to prevent lipodystrophy and local irritation
View sourceRoswell Park Comprehensive Cancer Center
Subcutaneous injection site selection: abdomen, thighs, upper arms
View sourceRoswell Park Comprehensive Cancer Center
Proper skin preparation: alcohol swab cleaning and air-drying before injection
View sourceInternational Journal of Molecular Sciences (PMC)
Preclinical studies: GHK-Cu activity at low doses (~0.5 mcg/kg in rats)
View sourceBrain Sciences (MDPI)
GHK effect on gene expression relevant to nervous system function and cognitive decline
View sourceCDC
Vaccine administration: subcutaneous injection technique (angle, no aspiration)
View sourceCDC (Subcutaneous Injection PDF)
Technique diagram and site guidance for subcutaneous injections
View sourceNCBI Bookshelf
Best practices for injection: asepsis, preparation, administration, and sharps disposal
View source
Educational content adapted from peptidedosages.com. Not medical advice.